ESR2, estrogen receptor 2, 2100

N. diseases: 528; N. variants: 56
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.070 AlteredExpression group BEFREE To investigate the relative expression of ERα and ERβ in multiple and solitary uterine leiomyomas, we collected samples from 35 Chinese women (multiple leiomyomas n = 20, solitary leiomyoma n = 15) undergoing surgery to remove uterine leiomyomas. 26529545 2016
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.070 GeneticVariation group BEFREE The TC genotype of the ERβ receptor polymorphism and the GA and AA genotypes of the PGR receptor polymorphism and their respective hormonal levels can be developed as markers in the prediction of uterine fibroids. 26715264 2016
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.070 AlteredExpression group BEFREE The protein expression of ERα, ERβ and aromatase was similar in leiomyoma and normal myometrium (p = 0.239, p = 0.695 and p = 0.203, respectively). 22377971 2012
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.070 GeneticVariation group BEFREE In conclusion, our data clearly suggest that the tested SNPs in the promotor region of human ESR2 gene are not associated with the development of uterine fibroids. 19639498 2010
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.070 GeneticVariation group BEFREE Further studies are still needed to explore the complicated interaction between environmental factors and ESR2 polymorphisms in the risk of uterine leiomyoma, particularly in ethnically different populations. 19715484 2009
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.070 Biomarker group BEFREE A prospective study focusing on leiomyoma was conducted to investigate the expression of estrogen receptor-alpha (ER alpha), estrogen receptor-beta (ER beta) and insulin-like growth factor-I (IGF-I) to elucidate their roles in the pathogenesis of leiomyoma. 19012097 2008
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
0.070 Biomarker group BEFREE Using fluorescence in situ hybridization and radiation hybrid mapping, we map ESR2 within 14q23-24.1, to a region approximately 2 Mb centromeric to the t(12;14) breakpoint in uterine leiomyomata, between markers D14S63 and WI-7536. 9824210 1998